Lannett Co Company Profile (NYSE:LCI)

About Lannett Co

Lannett Co logoLannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LCI
  • CUSIP: 51601210
Key Metrics:
  • Previous Close: $22.40
  • 50 Day Moving Average: $20.86
  • 200 Day Moving Average: $25.48
  • 52-Week Range: $37,189,000.00 - $16.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 7.00
  • P/E Growth: 0.94
  • Market Cap: $833.03M
  • Outstanding Shares: 37,189,000
  • Beta: 2.24
  • Net Margins: -3.48%
  • Return on Equity: 21.95%
  • Return on Assets: 6.79%
  • Debt-to-Equity Ratio: 1.62%
  • Current Ratio: 2.00%
  • Quick Ratio: 1.61%
Additional Links:
Companies Related to Lannett Co:

Analyst Ratings

Consensus Ratings for Lannett Co (NYSE:LCI) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $30.00 (33.93% upside)

Analysts' Ratings History for Lannett Co (NYSE:LCI)
DateFirmActionRatingPrice TargetDetails
2/2/2017Roth CapitalSet Price TargetBuy$28.00View Rating Details
12/6/2016Oppenheimer Holdings, Inc.Reiterated RatingHoldView Rating Details
10/18/2016Deutsche Bank AGReiterated RatingHold$32.00 -> $26.00View Rating Details
8/24/2016Raymond James Financial, Inc.Boost Price TargetOutperform$31.00 -> $43.00View Rating Details
3/25/2016Susquehanna Bancshares IncLower Price Target$37.00 -> $30.00View Rating Details
3/25/2016Craig HallumLower Price TargetBuy$35.00View Rating Details
3/24/2016Canaccord GenuityDowngradeBuy -> Sell$28.00 -> $18.00View Rating Details
(Data available from 2/19/2015 forward)


Earnings History for Lannett Co (NYSE:LCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/1/2017Q217$0.84$0.92$169.04 million$171.00 millionViewListenView Earnings Details
11/3/2016Q117$0.71$0.77$166.72 million$161.60 millionViewN/AView Earnings Details
8/23/2016Q416$0.59$0.73$161.55 million$168.90 millionViewListenView Earnings Details
5/3/2016Q316$0.63$0.75$160.49 million$163.70 millionViewN/AView Earnings Details
2/3/2016Q216$0.94$0.95$141.62 million$127.06 millionViewN/AView Earnings Details
11/4/2015Q116$0.89$0.99$103.90 million$106.40 millionViewN/AView Earnings Details
8/25/2015Q415$0.86$0.91$99.30 millionViewListenView Earnings Details
5/6/2015Q315$0.94$0.97$101.10 million$99.40 millionViewN/AView Earnings Details
2/4/2015Q215$1.06$1.21$102.95 million$114.80 millionViewN/AView Earnings Details
11/3/2014Q115$0.79$0.94$91.40 million$93.40 millionViewN/AView Earnings Details
8/27/2014Q414$0.54$0.64$79.50 million$80.60 millionViewN/AView Earnings Details
5/7/2014Q314$0.60$0.63$84.50 million$80.00 millionViewN/AView Earnings Details
2/6/2014Q214$0.39$0.46$62.21 million$67.30 millionViewN/AView Earnings Details
11/7/2013Q114$0.13$0.22$41.14 million$45.82 millionViewN/AView Earnings Details
9/10/2013Q4 2013$0.07$0.12$37.89 million$40.20 millionViewN/AView Earnings Details
5/8/2013Q3 2013$0.13$0.14$35.14 million$39.00 millionViewN/AView Earnings Details
2/7/2013Q2 2013$0.05$0.10$33.53 million$36.60 millionViewN/AView Earnings Details
11/8/2012Q113$0.05$0.07$33.76 million$35.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Lannett Co (NYSE:LCI)
Current Year EPS Consensus Estimate: $3.46 EPS
Next Year EPS Consensus Estimate: $3.20 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.60$0.91$0.77
Q2 20167$0.62$1.10$0.93
Q4 20163$0.59$0.60$0.60
Q1 20173$0.65$0.73$0.69
Q2 20173$0.80$0.91$0.86
Q3 20173$0.82$0.93$0.89
Q4 20173$0.86$0.95$0.91
Q1 20181$0.68$0.68$0.68
Q2 20181$0.76$0.76$0.76
Q3 20181$0.72$0.72$0.72
Q4 20181$0.73$0.73$0.73
(Data provided by Zacks Investment Research)


Dividend History for Lannett Co (NYSE:LCI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Lannett Co (NYSE:LCI)
Insider Ownership Percentage: 15.04%
Institutional Ownership Percentage: 80.82%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/6/2017Arthur P BedrosianCEOBuy10,000$20.00$200,000.00View SEC Filing  
12/2/2016David FarberMajor ShareholderSell3,800$25.00$95,000.00View SEC Filing  
9/15/2016G. Michael LandisInsiderSell4,334$32.30$139,988.20View SEC Filing  
9/1/2016James M MaherDirectorSell1,478$33.91$50,118.98View SEC Filing  
8/31/2016G. Michael LandisInsiderSell6,786$33.41$226,720.26View SEC Filing  
6/23/2016Robert EhlingerVPSell37,141$25.06$930,753.46View SEC Filing  
6/20/2016Robert EhlingerVPSell62,859$25.40$1,596,618.60View SEC Filing  
3/1/2016Robert EhlingerVPSell69,247$25.41$1,759,566.27View SEC Filing  
2/5/2016Arthur P BedrosianCEOBuy4,500$24.91$112,095.00View SEC Filing  
2/5/2016David A DrabikDirectorBuy1,277$24.74$31,592.98View SEC Filing  
2/5/2016Kevin SmithVPBuy1,500$24.75$37,125.00View SEC Filing  
2/5/2016Martin P GalvanCFOBuy3,000$24.65$73,950.00View SEC Filing  
9/15/2015Arthur P BedrosianCEOSell5,000$55.64$278,200.00View SEC Filing  
9/8/2015John AbtVPBuy1,000$54.77$54,770.00View SEC Filing  
8/17/2015Arthur P BedrosianCEOSell5,000$52.81$264,050.00View SEC Filing  
7/15/2015Arthur P BedrosianCEOSell5,000$61.92$309,600.00View SEC Filing  
6/15/2015Arthur P BedrosianCEOSell5,000$56.31$281,550.00View SEC Filing  
5/15/2015Arthur P BedrosianCEOSell5,000$53.27$266,350.00View SEC Filing  
4/15/2015Arthur P BedrosianCEOSell5,000$69.43$347,150.00View SEC Filing  
3/16/2015Arthur P BedrosianCEOSell5,000$65.23$326,150.00View SEC Filing  
3/16/2015William SchreckCOOSell134,635$64.99$8,749,928.65View SEC Filing  
3/6/2015William SchreckCOOSell50,000$63.35$3,167,500.00View SEC Filing  
2/18/2015David A DrabikDirectorSell12,500$61.55$769,375.00View SEC Filing  
2/17/2015Arthur P BedrosianCEOSell5,000$59.89$299,450.00View SEC Filing  
2/17/2015G. Michael LandisInsiderSell11,500$58.60$673,900.00View SEC Filing  
2/13/2015Jeffrey FarberDirectorSell35,000$58.18$2,036,300.00View SEC Filing  
2/11/2015Kevin SmithVPSell109,436$56.51$6,184,228.36View SEC Filing  
2/9/2015David FarberMajor ShareholderSell2,500$55.00$137,500.00View SEC Filing  
2/9/2015Kevin SmithVPSell53,534$55.36$2,963,642.24View SEC Filing  
2/6/2015G. Michael LandisInsiderSell12,049$52.93$637,753.57View SEC Filing  
1/26/2015David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
1/15/2015Arthur P BedrosianCEOSell5,000$43.50$217,500.00View SEC Filing  
12/15/2014Arthur P BedrosianCEOSell5,000$43.81$219,050.00View SEC Filing  
12/10/2014Martin P GalvanCFOBuy1,000$42.40$42,400.00View SEC Filing  
12/8/2014Ernest SaboVPSell6,000$48.03$288,180.00View SEC Filing  
10/27/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
9/16/2014Arthur P BedrosianCEOSell5,000$40.05$200,250.00View SEC Filing  
8/18/2014David FarberMajor ShareholderSell5,000$41.30$206,500.00View SEC Filing  
7/15/2014Arthur P BedrosianCEOSell5,000$47.19$235,950.00View SEC Filing  
6/23/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
6/16/2014Arthur P BedrosianCEOSell5,000$46.96$234,800.00View SEC Filing  
6/16/2014David FarberMajor ShareholderSell10,000$43.53$435,300.00View SEC Filing  
6/16/2014Paul TaveiraDirectorSell1,000$46.94$46,940.00View SEC Filing  
3/17/2014William SchreckCOOSell16,600$43.85$727,910.00View SEC Filing  
3/12/2014William SchreckCOOSell55,563$43.31$2,406,433.53View SEC Filing  
2/20/2014Kevin SmithVPSell64,665$45.11$2,917,038.15View SEC Filing  
2/13/2014Kevin SmithVPSell20,000$40.48$809,600.00View SEC Filing  
12/13/2013Arthur BedrosianCEOBuy5,000$27.85$139,250.00View SEC Filing  
12/13/2013Martin GalvanCFOBuy3,000$26.90$80,700.00View SEC Filing  
5/14/2013Kevin SmithVPSell24,984$11.86$296,310.24View SEC Filing  
5/13/2013Kevin SmithVPSell41,929$11.80$494,762.20View SEC Filing  
5/10/2013Ernest SaboVPSell15,000$11.29$169,350.00View SEC Filing  
3/14/2013Paul TaveiraDirectorBuy1,000$9.73$9,730.00View SEC Filing  
2/13/2013Martin P GalvanCFOBuy4,000$6.88$27,520.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Lannett Co (NYSE:LCI)
DateHeadline logoWill Lannett (LCI) Continue to Surge Higher? (NYSE:LCI) - February 16 at 4:58 PM
News IconForward Earnings Estimate of Lannett Co Inc(LCI) - Highland Mirror (NYSE:LCI) - February 11 at 12:07 AM logoCEO Buys Shares of Lannett (NYSE:LCI) - February 8 at 7:01 PM logoLannett completes extraction of ERP system from Kremers Urban (NYSE:LCI) - February 7 at 7:32 PM logoLannett Announces Successful Completion Of ERP System Extraction (NYSE:LCI) - February 7 at 7:32 PM logoLannett Co., Inc. :LCI-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017 (NYSE:LCI) - February 7 at 7:32 PM
News IconCEO of Lannett Co Inc (NYSE:LCI), Bedrosian Arthur P, buys 10,000 shares worth $200,000 (NYSE:LCI) - February 7 at 4:24 AM
News IconMuhlenkamp & Co INC Trimmed Lannet INC Com (LCI) Stake by $3.47 Million; Stock Value Rose (NYSE:LCI) - February 6 at 6:23 PM logoAcelRx Pharmaceuticals (ACRX) in Focus: Stock Rises 5.3% (NYSE:LCI) - February 6 at 10:13 AM logoAffimed (AFMD) Shows Strength: Stock Moves 8.1% Higher (NYSE:LCI) - February 6 at 10:13 AM
News IconLannett Co Inc (NYSE:LCI) EPS Projection Set At $0.73 – Transcript ... - Transcript Daily (NYSE:LCI) - February 5 at 6:01 PM logoLannett Co Inc (NYSE:LCI) Analysts Rating At 2 - (NYSE:LCI) - February 5 at 6:01 PM
News IconLannett Co Inc (NYSE:LCI) Quarterly EPS Projection At $0.85 | Stock ... - Stock Observer (NYSE:LCI) - February 5 at 6:01 PM
News IconLannett Company, Incorporated (NYSE:LCI) predictive Earnings Analysis (NYSE:LCI) - February 4 at 4:57 AM logoStrong Earnings Numbers Ramp Up Pressure For Possible Lannett Short Squeeze - Benzinga (NYSE:LCI) - February 3 at 6:55 PM logoStrong Earnings Numbers Ramp Up Pressure For Possible Lannett Short Squeeze (NYSE:LCI) - February 2 at 6:58 PM logo4:23 pm Lannett beats by $0.08, beats on revs; reaffirms FY17 rev guidance (NYSE:LCI) - February 2 at 6:58 PM logoEdited Transcript of LCI earnings conference call or presentation 1-Feb-17 9:30pm GMT (NYSE:LCI) - February 2 at 5:06 AM logoLannett Company's (LCI) CEO Arthur Bedrosian on Q2 2017 Results - Earnings Call Transcript (NYSE:LCI) - February 2 at 12:05 AM logoQ2 2017 Lannett Company Inc Earnings Release - After Market Close (NYSE:LCI) - February 1 at 7:03 PM logoLannett Reports Fiscal 2017 Second-Quarter Financial Results (NYSE:LCI) - February 1 at 7:03 PM logoLannett tops Street 2Q forecasts (NYSE:LCI) - February 1 at 7:03 PM logoLannett : Cody Labs expansion gets final OK (NYSE:LCI) - January 31 at 7:05 PM logoLANNETT COMPANY,INC. (NYSE:LCI) Files An 8-K Regulation FD Disclosure (NYSE:LCI) - January 31 at 7:05 PM
News IconGeneric Drugs Stocks on Investors' Radar -- Ironwood Pharma, Medicines, Rigel Pharma, and Lannett (NYSE:LCI) - January 30 at 10:14 AM
News IconAs Lannet INC (LCI) Stock Rose, Telemus Capital LLC Has Boosted Its Position (NYSE:LCI) - January 27 at 1:04 AM logoLANNETT COMPANY,INC. (NYSE:LCI) Files An 8-K Submission of Matters to a Vote of Security Holders - Market Exclusive (NYSE:LCI) - January 26 at 8:03 PM
News IconEarnings in Full Force, Analysts Take Aim at Lannett Co Inc (NYSE:LCI) - Wall Street Beacon (NYSE:LCI) - January 26 at 8:03 PM logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Lannett Company, Inc. -LCI - PR Newswire (press release) (NYSE:LCI) - January 26 at 8:03 PM logoSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Lannett Company, Inc. -LCI (NYSE:LCI) - January 26 at 12:40 AM logoLannett To Report Fiscal 2017 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 1 (NYSE:LCI) - January 25 at 7:38 PM logoLANNETT CO INC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders (NYSE:LCI) - January 25 at 7:38 PM logoRobbins Arroyo LLP: Lannett Company, Inc. (LCI) Misled Shareholders According to a Recently Filed Class Action (NYSE:LCI) - January 23 at 6:34 PM logoLannett Voluntarily Pays Down $75 Million Of Revolving Credit Facility (NYSE:LCI) - January 23 at 10:31 AM
News IconLannett Company, Inc. (NYSE:LCI) shows monthly volitility of 5.77 ... - The Newburgh Press (NYSE:LCI) - January 20 at 4:33 PM logoLANNETT COMPANY,INC. (NYSE:LCI) Files An 8-K Submission of Matters to a Vote of Security Holders (NYSE:LCI) - January 19 at 8:03 PM logoLANNETT CO INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NYSE:LCI) - January 19 at 8:03 PM logoLannett: Citron Exposes The Lawsuits That Will Wipe Out The Equity (NYSE:LCI) - January 18 at 11:45 PM
News IconLannett Co Inc (NYSE:LCI) Price Target Predicted At $31.75 - Transcript Daily (NYSE:LCI) - January 18 at 4:40 AM
News IconNotable Tuesday Option Activity: LCI, HLF, UBNT (NYSE:LCI) - January 17 at 6:37 PM logoCitron Research Negative on Lannett (LCI); Sees Shares at 'Zero' Over Long Term (NYSE:LCI) - January 17 at 6:37 PM logoCitron On Lannett: Price Gouging At Its Worst, Will Be First To Go Bankrupt (NYSE:LCI) - January 17 at 6:37 PM
News IconLannett Company (LCI) Stock: Citron Says It’s Going To Zero! (NYSE:LCI) - January 17 at 6:37 PM
News IconEPS Projection Of Lannett Co Inc (NYSE:LCI) At $ 0.73EPS ... - Transcript Daily (NYSE:LCI) - January 16 at 8:22 AM
News IconEPS Of Lannett Co Inc (NYSE:LCI) At $0.83 - Stock Observer (NYSE:LCI) - January 16 at 8:22 AM
News IconHow Does the Chart Look for Lannett Company, Inc. (LCI) ? - The USA Commerce (NYSE:LCI) - January 16 at 8:22 AM logoLannett Co Inc (NYSE:LCI) Analysts Rating At 2 (NYSE:LCI) - January 15 at 5:52 PM logoUPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Lannett Company, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 (NYSE:LCI) - January 13 at 7:30 PM logoBernstein Liebhard LLP Announces That Only Four Days Remain To File A Motion For Lead Plaintiff In A Class Action Suit Against Lannett Company, Inc. (NYSE:LCI) - January 13 at 7:30 PM logoHarwood Feffer LLP Announces Investigation of Lannett Company Inc. (NYSE:LCI) - January 13 at 7:30 PM


What is Lannett Co's stock symbol?

Lannett Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Where is Lannett Co's stock going? Where will Lannett Co's stock price be in 2017?

6 brokers have issued twelve-month price targets for Lannett Co's shares. Their forecasts range from $18.00 to $43.00. On average, they expect Lannett Co's share price to reach $30.00 in the next year.

When will Lannett Co announce their earnings?

Lannett Co is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

Who owns Lannett Co stock?

Lannett Co's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Deerfield Management Co. (5.40%), State Street Corp (3.22%), Dimensional Fund Advisors LP (2.63%), Thompson Siegel & Walmsley LLC (2.42%), Russell Investments Group Ltd. (1.16%) and FMR LLC (0.96%). Company insiders that own Lannett Co stock include Arthur P Bedrosian, David A Drabik, David Farber, G Michael Landis, James M Maher, John Abt, Kevin Smith, Martin P Galvan, Robert Ehlinger and William Schreck.

Who sold Lannett Co stock? Who is selling Lannett Co stock?

Lannett Co's stock was sold by a variety of institutional investors in the last quarter, including Pinnacle Associates Ltd., State Board of Administration of Florida Retirement System, Cantab Capital Partners LLP, Tudor Investment Corp Et Al and New York State Teachers Retirement System. Company insiders that have sold Lannett Co stock in the last year include David Farber, G Michael Landis, James M Maher and Robert Ehlinger.

Who bought Lannett Co stock? Who is buying Lannett Co stock?

Lannett Co's stock was bought by a variety of institutional investors in the last quarter, including Deerfield Management Co., Russell Investments Group Ltd., FMR LLC, Thompson Siegel & Walmsley LLC, State Street Corp, Oxford Asset Management, Westwood Holdings Group Inc. and Dimensional Fund Advisors LP. Company insiders that have bought Lannett Co stock in the last two years include Arthur P Bedrosian, David A Drabik, John Abt, Kevin Smith and Martin P Galvan.

How do I buy Lannett Co stock?

Shares of Lannett Co can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Lannett Co stock cost?

One share of Lannett Co stock can currently be purchased for approximately $22.40.

Lannett Co (NYSE:LCI) Chart for Sunday, February, 19, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Lannett Co (NYSE:LCI)

Earnings History Chart

Earnings by Quarter for Lannett Co (NYSE:LCI)

Dividend History Chart

Dividend Payments by Quarter for Lannett Co (NYSE:LCI)

Last Updated on 2/19/2017 by Staff